BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Valproic acid
,
rs2476601
,
BRAF
,
Apoptosis
,
Breast Cancer
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FREAC2_01
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Vagina
Urethra
Myometrium
Saphenous vein
Tonsil
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Periodontitis
Drug resistance
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
GSK-1059615
A 443654
tizanidine
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
DROSHA
PPP2R2C
NR5A1
NOP2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
Glomerulonephrotic and healthy tissue from C57BL6.MRLc1 congenic mice
Adult T-cell Leukemia (ATL) cells and in Normal CD4+ T-cells miRNA expression
Follicular fluid miRNA profiles during the development of the oocyte
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for FREAC2_01
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for FREAC2_01
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ